These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35852165)

  • 1. Evaluation of platelet-rich plasma efficacy in melasma.
    Acar A; Ozturk A; Sokmen N; Unal I; Ertam Sagduyu I
    J Cosmet Laser Ther; 2022 Jul; 24(1-5):36-39. PubMed ID: 35852165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-rich plasma treatment for melasma: A pilot study.
    Sirithanabadeekul P; Dannarongchai A; Suwanchinda A
    J Cosmet Dermatol; 2020 Jun; 19(6):1321-1327. PubMed ID: 31568636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative evaluation of the efficacy of intralesional tranexamic acid versus platelet rich plasma in the treatment of melasma.
    Patil NK; Bubna AK
    Dermatol Ther; 2022 Jul; 35(7):e15534. PubMed ID: 35460158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-rich plasma is a useful therapeutic option in melasma.
    Hofny ERM; Abdel-Motaleb AA; Ghazally A; Ahmed AM; Hussein MRA
    J Dermatolog Treat; 2019 Jun; 30(4):396-401. PubMed ID: 30220226
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparing the Efficacy of Patelet-rich Plasma (PRP) versus Tranexamic Acid (4mg/mL) as Intradermal Treatments of Melasma.
    Mumtaz M; Chandio TH; Shahzad MK; Hanif N; Anwar S; Rafique S
    J Coll Physicians Surg Pak; 2021 May; 31(5):502-505. PubMed ID: 34027858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of melasma with platelet-rich plasma: A self-controlled clinical trial.
    González-Ojeda A; Cervantes-Guevara G; Chejfec-Ciociano JM; Cervantes-Cardona GA; Acevedo-Guzman D; Puebla-Mora AG; Cortés-Lares JA; Chávez-Tostado M; Álvarez-Villaseñor AS; Cervantes-Pérez E; Ramos-Álvarez MP; Pacheco-Vallejo LR; Barbosa-Camacho FJ; Fuentes-Orozco C
    Dermatol Ther; 2022 Sep; 35(9):e15703. PubMed ID: 35831241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-Rich Plasma in Melasma-A Systematic Review.
    Sarkar R; Gupta M
    Dermatol Surg; 2022 Jan; 48(1):131-134. PubMed ID: 34904579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intradermal injection of tranexamic acid versus platelet-rich plasma in the treatment of melasma: a split-face comparative study.
    Abd Elraouf IG; Obaid ZM; Fouda I
    Arch Dermatol Res; 2023 Aug; 315(6):1763-1770. PubMed ID: 36856856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of autologous platelet rich plasma and hydroquinone 4% is more effective than hydroquinone alone in treatment of melasma: A split-face comparative study.
    Tekam PS; Belgaumkar VA
    Dermatol Ther; 2022 Nov; 35(11):e15761. PubMed ID: 36068674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of autologous platelet-rich-plasma versus its combination with intense pulsed light in treatment of melasma.
    Adel S; Serri A; Abd El-Raheem T
    Dermatol Ther; 2021 Jul; 34(4):e15008. PubMed ID: 34041826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Platelet-Rich Plasma Therapy as an Adjuvant in Treatment of Melasma.
    Bikash C; Sarkar R; Relhan V; Singh S
    Dermatol Surg; 2022 Apr; 48(4):429-434. PubMed ID: 35143442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous intralesional platelet rich plasma improves melasma.
    Tuknayat A; Thami GP; Bhalla M; Sandhu JK
    Dermatol Ther; 2021 Mar; 34(2):e14881. PubMed ID: 33591615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of combined fractional CO
    Tawfic SO; Abdel Halim DM; Albarbary A; Abdelhady M
    Lasers Surg Med; 2019 Jan; 51(1):27-33. PubMed ID: 30431171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of cysteamine cream in the treatment of epidermal melasma, evaluating by Dermacatch as a new measurement method: a randomized double blind placebo controlled study.
    Farshi S; Mansouri P; Kasraee B
    J Dermatolog Treat; 2018 Mar; 29(2):182-189. PubMed ID: 28678558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of clinical results of oral tranexamic acid and platelet rich plasma therapies in melasma treatment.
    Polat Y; Saraç G
    Dermatol Ther; 2022 Jul; 35(7):e15499. PubMed ID: 35395121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The first clinical experience on efficacy of topical flutamide on melasma compared with topical hydroquinone: a randomized clinical trial.
    Adalatkhah H; Sadeghi-Bazargani H
    Drug Des Devel Ther; 2015; 9():4219-25. PubMed ID: 26345129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of TGF-β protein in the lesional skins of melasma patients following treatment with platelet-rich plasma.
    Hofny ERM; Hussein MRA; Ghazally A; Ahmed AM; Abdel-Motaleb AA
    J Cosmet Laser Ther; 2019; 21(7-8):382-389. PubMed ID: 31554441
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and safety of intense pulsed light in treatment of melasma in Chinese patients.
    Li YH; Chen JZ; Wei HC; Wu Y; Liu M; Xu YY; Dong GH; Chen HD
    Dermatol Surg; 2008 May; 34(5):693-700; discussion 700-1. PubMed ID: 18318729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study between topical tranexamic acid alone versus its combination with autologous platelet rich plasma for treatment of melasma.
    Gamea MM; Kamal DA; Donia AA; Hegab DS
    J Dermatolog Treat; 2022 Mar; 33(2):798-804. PubMed ID: 32567984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cream of herbal mixture to improve melasma.
    Zhang Q; Tu Y; Gu H; Sun D; Wu W; Man MQ; Chen H; Liu H; Ma X; He L
    J Cosmet Dermatol; 2019 Dec; 18(6):1721-1728. PubMed ID: 30980618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.